Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.

Saved in:
Bibliographic Details
Title: Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Authors: Böll B; Laboratory of Immunotherapy, Department of Hematology and Oncology, University Hospital Cologne, Cologne, Germany. boris.boell@uk.koeln.de, Eltaib F, Reiners KS, von Tresckow B, Tawadros S, Simhadri VR, Burrows FJ, Lundgren K, Hansen HP, Engert A, von Strandmann EP
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2009 Aug 15; Vol. 15 (16), pp. 5108-16. Date of Electronic Publication: 2009 Aug 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19671844
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Böll+B%22">Böll B</searchLink>; Laboratory of Immunotherapy, Department of Hematology and Oncology, University Hospital Cologne, Cologne, Germany. boris.boell@uk.koeln.de<br /><searchLink fieldCode="AU" term="%22Eltaib+F%22">Eltaib F</searchLink><br /><searchLink fieldCode="AU" term="%22Reiners+KS%22">Reiners KS</searchLink><br /><searchLink fieldCode="AU" term="%22von+Tresckow+B%22">von Tresckow B</searchLink><br /><searchLink fieldCode="AU" term="%22Tawadros+S%22">Tawadros S</searchLink><br /><searchLink fieldCode="AU" term="%22Simhadri+VR%22">Simhadri VR</searchLink><br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink><br /><searchLink fieldCode="AU" term="%22Lundgren+K%22">Lundgren K</searchLink><br /><searchLink fieldCode="AU" term="%22Hansen+HP%22">Hansen HP</searchLink><br /><searchLink fieldCode="AU" term="%22Engert+A%22">Engert A</searchLink><br /><searchLink fieldCode="AU" term="%22von+Strandmann+EP%22">von Strandmann EP</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2009 Aug 15; Vol. 15 (16), pp. 5108-16. <i>Date of Electronic Publication: </i>2009 Aug 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19671844
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-09-0213
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5108
    Titles:
      – TitleFull: Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Böll B
      – PersonEntity:
          Name:
            NameFull: Eltaib F
      – PersonEntity:
          Name:
            NameFull: Reiners KS
      – PersonEntity:
          Name:
            NameFull: von Tresckow B
      – PersonEntity:
          Name:
            NameFull: Tawadros S
      – PersonEntity:
          Name:
            NameFull: Simhadri VR
      – PersonEntity:
          Name:
            NameFull: Burrows FJ
      – PersonEntity:
          Name:
            NameFull: Lundgren K
      – PersonEntity:
          Name:
            NameFull: Hansen HP
      – PersonEntity:
          Name:
            NameFull: Engert A
      – PersonEntity:
          Name:
            NameFull: von Strandmann EP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 08
              Text: 2009 Aug 15
              Type: published
              Y: 2009
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1